Article Per Year (5 Year)
p-Index From 2021 - 2026
3.51
P-Index
This Author published in this journals
All Journal Acta Interna : The Journal of Internal Medicine Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Medical Journal of Indonesia The Indonesian Biomedical Journal Indonesian Journal of Cardiology ACI (Acta Cardiologia Indonesiana) Journal of Community Empowerment for Health JK Unila (Jurnal Kedokteran Universitas Lampung) Berita Kedokteran Masyarakat Advances In Social Humanities Research Indonesian Journal of Biomedicine and Clinical Sciences Indonesian Journal of Pharmacology and Therapy
Anggoro Budi Hartopo
Department Of Cardiology And Vascular Medicine, Faculty Of Medicine, Public Health And Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Working Group On Pulmonary Hypertension, Indonesian Heart Association
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Dentistry Education Engineering Environmental Science Health Professions Immunology & microbiology Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences

Published : 42 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 42 Documents
Search

 1   2   3   4   5 
Simplified Selvester QRS Score as an Infarct Size Parameter in STEMI Patients Undergoing Pharmacoinvasive or Primary Percutaneous Coronary Intervention Prasetia, Arif Eka; Hartopo, Anggoro Budi; Taufiq, Nahar; Bagaswoto, Hendry Purnasidha; Setianto, Budi Yuli
Jurnal Kardiologi Indonesia Vol 43 No 4 (2022): Indonesian Journal of Cardiology: October - December 2022
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1186

Abstract

Background:Cardiovascular disease especially acute myocardial infarct (AMI) is one of the highest cause of mortality worldwide. Majority of AMI comes in the form of ST elevation myocardial infarct (STEMI) that requires timely diagnosis and revascularization management to restore myocardial circulation. The simple method to estimate infarct size is by using simplified Selvester QRS Score to electrocardiogram records, which is a tested method that have good correlation with gold standard, namely cardiac magnetic resonance imaging. Objectives : To investigate difference of infarct size with simplified Selvester QRS score parameter between STEMI patients undergoing pharmacoinvasive compared to primary PCI. Methods: Eighty-two STEMI patients, 41 of pharmacoinvasive and 41 of primary PCI was scored with simplified Selvester QRS score from electrocardiogram recording. Patient data are retroactively taken form Sardjito Cardiovascular Intensive Care (SCIENCE) registry. Scoring of simplified Selvester QRS Score was done by two experienced cardiologist blinded to patient procedure, and results then measured for interobserver agreement with Bland-Altman test. Comparison of QRS Score in pharmacoinvasive and primary PCI group was done with independent sample T test followed with multivariable linear regression test. Results: The means of simplified Selvester QRS score in pharmacoinvasive and primary PCI group is 7.240±3.015 and 8.900±4.188, p=0.043, respectively. Independent sample T test shows significant difference in the simplified Selvester QRS score in pharmacoinvasive and primary PCI group. The multivariable analysis shows that variables other than revascularization method independently influences QRS score are onset, anterior segment ST elevation and ST segment elevation in more > 3 leads in electrocardiogram. Conclusion: There is significant difference in infarct size measured by simplified Selvester QRS score betweem STEMI patient undergoing pharmacoinvasive method compared to primary PCI procedure, which is lower in the pharmacoinvasive group This article has a related Erratum.
Kardioversi Listrik yang Berhasil pada Wanita Kehamilan Tahap Akhir dengan Takikardia Supraventrikular Setiaji, Dimas; Jati, Lintang Daru; Shiddiq, Achmad; Hartopo, Anggoro Budi; Arso, Irsad Andi
Jurnal Kardiologi Indonesia Vol 44 No 4 (2023): Indonesian Journal of Cardiology: October - December 2023
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1280

Abstract

Background: Pregnancy, precipitate cardiac arrhythmia, and supraventricular tachycardia (SVT) are some most frequent and sustained arrhythmias in pregnancy. In general, the pharmacological approach in pregnant patient is similar to that in the non-pregnant patient. However, fetal safety becomes a special consideration before administering the therapy. Case Presentation: We reported a 34-year-old female G3P2A0 with 35 weeks of gestation who came to the emergency department with sudden onset palpitations within 2 hours before admission. She had no prior history of any major medical illness. The clinical examination revealed that the patient had a regular pulse rate of 198/minute, and the blood pressure was 80/50 mmHg. The electrocardiogram showed the presence of SVT. Synchronized cardioversion with 50 joules was performed. The patient’s rhythm was converted to sinus tachycardia with a pulse rate of 120/minute and blood pressure was 90/60 mmHg. The patient was admitted to ICCU immediately after cardioversion and discharged from the hospital without any adverse effects after two days of monitoring. Conclusion: SVT is arrhythmia condition that is often found in pregnant women. In an unstable SVT condition, cardioversion is the first general action that is safe to be performed on the mother and the fetus. It must have strict observation before and after cardioversion to monitor whether there was a problem with the fetus or not.
Improvement in left ventricle geometry and function after kidney transplantation Baiq Gerisa Rahmi Faharani; Hasanah Mumpuni; Yulia Wardhani; Metalia Puspitasari; Raden Heru Prasanto; Iri Kuswadi; Anggoro Budi Hartopo
Indonesian Journal of Biomedicine and Clinical Sciences Vol 56 No 01 (2024)
Publisher : Published by Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/inajbcs.v56i01.11774

Abstract

Chronic kidney disease (CKD) is associated with remodeling of the left ventricle (LV), affecting both its geometry and function. Kidney transplantation in patients with stage 5 CKD may lead to improvements in LV remodeling and result in better cardiac function. The aim of the study was to determine changes and improvements in LV geometry and function after kidney transplantation in patients with stage 5 CKD. This was an observational study conducted by collecting secondary data from the Hospital's Kidney Transplantation Registry, Dr. Sardjito General Hospital spanning the years 2017 to 2020. The study employed a comparative design, contrasting the results before and after treatment (kidney transplantation). We compared transthoracic echocardiographic parameters for LV geometry and function before and after kidney transplantation. The evaluation timeframe after kidney transplantation was divided into <12 and ³12 mo. A total of 27 patients qualified for inclusion in this study. In the <12 mon (n=20) evaluation group, there was a reduction in proportion of LV hypertrophy from 70% to 45%. There was an increase in global LV systolic function (ejection fraction) from 60.1±10.95% to 67.85±6.48% (p=0.014), and a decrease in LV diastolic dysfunction from 45% to 15% (p=0.07). In the ³12 mon (n=11) evaluation group, there was a decrease in the proportion of LV hypertrophy from 81.8 to 54.5%, an increase in global LV systolic function (ejection fraction) from 57.73±13.07% to 69.36±6.12% (p=0.011), and a decreased LV diastolic dysfunction from 63.6% to 0% (p=0.016). In conclusion, significant changes in LV geometry and function are observed following kidney transplantation, indicating improvements in these parameters. There are improvements in LV systolic function started at <12 mo and in LV diastolic function at ³12 mo after kidney transplantation.
Association between chemotherapy-related cardiac dysfunction (CTRCD) and 6-minute walking distance (6MWD) in breast cancer patient receiving anthracycline-based chemotherapy Putri Ayudhia Trisnasari; Irsad Andi Arso; Hasanah Mumpuni; Vita Yanti Anggraeni; Susanna Hilda Hutajulu; Mardiah Suci Hardianti; Hartopo, Anggoro Budi
Indonesian Journal of Biomedicine and Clinical Sciences Vol 56 No 4 (2024)
Publisher : Published by Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/inajbcs.v56i4.12240

Abstract

Anthracycline chemotherapy is one of the most commonly given therapies to breast cancer patients. Anthracycline has a cardiotoxicity effect causing cardiac myocyte death. This chemotherapy-related cardiac dysfunction (CTRCD) will decrease oxygen delivery to tissues characterized by reduced cardiorespiratory fitness. The 6-min walking distance (6MWD) could be a predictor of cardiorespiratory fitness. This study aimed to investigate the association between CTRCD and the reduction in 6MWD after receiving anthracycline-based chemotherapy. It was an analytical observational study with a retrospective cohort design that conducted on breast cancer patients underwent anthracycline-based chemotherapy. Subjects were patients from the Cardio-oncocare registry who met the inclusion and exclusion criteria. The CTRCD was assessed using left ventricle ejection fraction (LVEF) and global longitudinal strain (LVGLS) by transthoracic echocardiography examination based on criteria from the European Society of Cardiology guidelines. The 6MWD was assessed by performing 6-min walking tests. The LVEF, LVGLS and 6MWD data were retrieved from the Cardio-oncocare registry database, which were performed before and after chemotherapy. The changes and association of LVEF, LVGLS and 6MWD from before to end of chemotherapy were analyzed. Of 250 Cardio-oncocare registered patients, 58 patients met the criteria. Among them, 17 patients (29%) had CTRCD, and 41 patients (71%) had no CTRCD after chemotherapy. A significant decrease in LVEF and LVGLS in patients with CTRCD was observed. The 6MWD before chemotherapy did not statistically differ between CTRCD and no CTRCD patients. After chemotherapy, the proportion of patients experienced reduction of 6MWD was not significantly different between CTRCD patients and no CTRCD patients [7 patients (41%) vs. 21 patients (51%); p=0.342]. In conclusion, there is no significant association between CTRCD and reduction of 6MWD in breast cancer patients receiving antracycline-based chemotherapy.
Tekanan darah sistolik, indeks kardiak dan sindrome Eisenmenger merupakan prediktor kematian pada pasien hipertensi arteri pulmonal terkait penyakit jantung bawaan: analisis dari register COHARD-PH Rochmat, Muflihatul Baroroh; Setianto, Budi Yuli; Anggrahini, Dyah Wulan; Dinarti, Lucia Kris; Hartopo, Anggoro Budi
Jurnal Kardiologi Indonesia Vol 45 No 3 (2024): July - September, 2024
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1623

Abstract

Background: Pulmonary arterial hypertension (PAH) is a complication of left-to-right intracardiac shunt congenital heart disease (LtR-shunt CHD). There are several known predictors of mortality in PAH patients, however predictors of mortality in LtR-shunt CHD-associated PAH need to be validated. Objectives: We aimed to investigate the predictors of mortality among adult LtR-shunt CHD-associated PAH patients. Methods: This research was a retrospective cohort study that included adult patients with LtR-shunt CHD-associated PAH retrieved from the COHARD-PH registry. Several baseline variables were selected as potential predictors of mortality, namely (1) clinical data: WHO-functional class, SaO2, 6-min walking distance, systolic blood pressure, and Eisenmenger syndrome; (2) laboratory data: hemoglobin and NT-pro BNP levels; (3) echocardiography data: pericardial effusion, defect size, and TAPSE; and (4) hemodynamic data: right atrial pressure, cardiac output and index, SvO2, and flow ratio. The mortality outcome was assessed from the cohort registry. Results: A total of 124 subjects with LtR-shunt CHD-associated PAH were included. Sixteen subjects (12.9%) died during the follow-up period. The baseline variables which showed significant association with mortality were lower systolic blood pressure, Eisenmenger syndrome, higher NT-pro BNP level, and lower cardiac output. The multivariable analysis showed that systolic blood pressure <100 mmHg (OR 10.99; 95% CI 2.54-47.51, p=0.001), cardiac index <2.5 L/min/m2 (OR 8.13; 95% CI: 1.59-42.28, p=0.011) and Eisenmenger syndrome (OR 3.87; 95%CI: 1.06-14.07) were the independent predictors for mortality. Conclusions: The systolic blood pressure <100 mmHg, cardiac index <2.5 L/min/m2, and Eisenmenger syndrome were independent predictors of mortality among adults with LtR-shunt CHD-associated PAH.
Safety monitoring of chloroquine and hydroxychloroquine in COVID-19 patients in Indonesia on QT prolongation: hospital based monitoring study Jarir At Thobari; Togi Junice Hutadjulu; Tri Asti Isnariani; Umi Sa'adatun Nikmah; Lukman Ade Chandra; Pompini Agustina Sitompul; Anggoro Budi Hartopo; Rizki Amalia Gumilang; Luhur Pribadi; Deva Bachtiar; Anwar Santoso
Indonesian Journal of Pharmacology and Therapy Vol 4 No 1 (2023)
Publisher : Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada and Indonesian Pharmacologist Association or Ikatan Farmakologi Indonesia (IKAFARI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ijpther.7148

Abstract

Chloroquine (CQ) and Hydroxychloroquine (HCQ) are the challenging drugs used for COVID-19. Several studies show its beneficial, however, both medications can prolong the QTc interval and increase the risk of patients for torsades de pointes and death. The Tisdale score is identified to have successfully predicted the at-risk population of side effects of these drugs. This study aim to evaluate the QT prolongation caused by the administration of chloroquine and hydroxychloroquine in COVID-19 patients and the association with the treatment outcomes based on their Tisdale score. We conducted an observational study on 213 hospitalized patients with confirmed or suspect COVID-19 in 6 referral hospitals in Indonesia. All baseline demographic such as age and gender, RT-PCR test result, severity of disease, history of cardiovascular disease (myocardial infarction, heart failure, hypertension), serum kalium level at baseline, and the use of medication associated with risk QTc interval prolongation were collected. The Tisdale risk score was used for predicting high-risk patients for QT corrected (QTc) interval prolongation. Out of 213 patients who were treated with CQ/HCQ, there were 60 (28.2%) patients had QTc interval prolongation, included 43 patients (20.2%) who had normal QTc interval at baseline and at the end of treatment had prolong interval; or 17 patients (8.0%) who had QTc interval more than 470 msec at baseline and QTc interval prolongation was worsen at the end of treatment. Several factors, including age more than 50 years, COVID-19 confirm PCR, and had comorbidity heart failure, were statistically significant associated with QTc interval prolongation. The high-risk score of Tisdale score have increased risk significantly on QTc interval prolongation (RR: 2.15, 95%CI 1.07-4.32) and associated with risk of death (RR: 3.50, 95%CI 1.34-9.13) compared to low-risk score. Our findings showed that the treatment of CQ/HCQ in COVID-19 patients is associated with QTc prolongation. The Tisdale score can be used as a valuable tool to predict the COVID-19 patients’ outcome after treatment of these QTc-prolonging drugs.
Familial atrial septal defect: a case report in Indonesia Muhammad Gahan Satwiko; Lucia Kris Dinarti; Armalya Pritazahra; Abdul Majid Halim Wiradhika; Muhammad Reyhan Hadwiono; Dyah Wulan Anggrahini; Anggoro Budi Hartopo
Indonesian Journal of Biomedicine and Clinical Sciences Vol 57 No 1 (2025)
Publisher : Published by Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/inajbcs.v57i1.20213

Abstract

Familial atrial septal defect (ASD) is defined as the occurrence of ASD in the first-degree family of the ASD patient. Recently, familial ASD has been increasingly studied. Familial ASD could manifest as an isolated ASD or with other abnormalities. Furthermore, because ASD is usually asymptomatic, it is very difficult to recognize ASD in a first-degree family based only on symptoms. However, if the family was screened using electrocardiography or echocardiography, the occurrence of familial ASD could be found. Therefore, screening plays an important role in detecting familial ASD. We reported an ASD patient with several occurrences of familial ASD. ABSTRAK Atrial septal defect (ASD) familial didefinisikan sebagai terjadinya ASD di keluarga tingkat pertama pada pasien ASD. Studi mengenai ASD familial saat ini telah semakin banyak dilakukan. ASD familial dapat bermanifestasi sebagai ASD yang terisolasi ataupun ASD yang disertai dengan abnormalitas yang lain. Selain itu, karena ASD biasanya asimptomatik, sangat sulit mengenali ASD pada keluarga tingkat pertama hanya berdasarkan gejalanya. Meski demikian, jika keluarga tersebut diperiksa menggunakan elektrokardiografi atau ekokardiografi maka dapat ditemukan terjadinya ASD familial. Oleh karena itu, skrining memegang peranan penting dalam deteksi ASD familial. Kami melaporkan pasien ASD dengan beberapa kejadian ASD familial.
Impact of Cardiac Rehabilitation on Functional Aerobic Capacity in Coronary Artery Disease Patients Sjughiarto, M.Afies; Arso, Irsad Andi; Hartopo, Anggoro Budi
Advances In Social Humanities Research Vol. 3 No. 5 (2025): Advances In Social Humanities Research
Publisher : Sahabat Publikasi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/adv.v3i5.437

Abstract

Cardiac rehabilitation (CR) is a vital component of secondary prevention in patients with coronary artery disease (CAD), known to improve cardiorespiratory fitness (CRF), enhance quality of life, and reduce cardiovascular morbidity and mortality. This study aimed to examine the impact of physical activity status on functional aerobic capacity (FAC) and CRF classification, as well as to identify significant predictors of FAC among CAD patients. A cross-sectional study was conducted involving 104 CAD patients who underwent exercise stress testing. Participants were divided into three groups: (1) those who completed phase II CR within 30 days, (2) those who engaged in regular exercise without formal CR, and (3) physically inactive individuals. FAC was calculated as the ratio of achieved to predicted metabolic equivalents (METs) and used to classify CRF into four categories (A: <69%, B: 70–99%, C: 100–129%, D: ?130%). The Kruskal-Wallis test revealed a significant association between rehabilitation status and FAC scores (p=0.047). Patients who completed phase II CR had significantly higher FAC than physically inactive individuals (p=0.011). The inactive group showed the lowest FAC (mean 0.58), with most classified in the lowest CRF category. Quantile regression demonstrated that phase II CR positively influenced FAC at the 50th and 75th quantiles (p=0.048 and p=0.011, respectively), while residual ischemia had a negative effect (p=0.005 and p=0.025). In conclusion, phase II CR significantly improves FAC in CAD patients, particularly those with moderate to high baseline capacity. Tailored CR programs may be especially beneficial for patients with residual ischemia, supporting individualized approaches in clinical rehabilitation practice.
Indonesia-INTERASPIRE study: an Indonesian cross-sectional multicenter survey on cardiovascular secondary prevention in coronary heart disease Ambari, Ade Meidian; Hasan, Harris; Dwiputra, Bambang; Desandri, Dwita Rian; Hamdani, Rita; Krevani, Citra Kiki; Syaoqi, Muhammad; Ridwan, Muhammad; Anandini, Hesti; Fitra, Maha; Arso, Irsad Andi; Anggraeni, Vita Yanti; Hartopo, Anggoro Budi; Siregar, Yasmine Fitrina; Tjahjono, Cholid Tri; Tiksnadi, Badai Bhatara; Febrianora, Mega; Tarsidin, Najmi Fauzan; Arityanti, Dean; Qhabibi, Faqrizal Ria; Makes, Indira Kalyana; Susilowati, Eliana; Erwan, Nabila Erina; Hergaf, Indah Widyasari; Raynaldo, Abdul Halim
Medical Journal of Indonesia Vol. 34 No. 3 (2025): September
Publisher : Faculty of Medicine Universitas Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.13181/mji.oa.257833

Abstract

BACKGROUND Cardiovascular disease (CVD) is projected to affect more than 23.3 million people by 2030. Therefore, CVD prevention strategies were established to decrease morbidity and mortality while enhancing overall well-being. The Joint European Societies (JES) guidelines on CVD prevention were developed to enhance preventive cardiology practices. This study aimed to evaluate the adherence to JES guidelines for cardiovascular prevention in routine clinical practice for secondary prevention. METHODS This multicenter cross-sectional study was conducted in 7 centers between August 2020 and June 2021. Patients under 80 years old who had undergone percutaneous transluminal coronary angioplasty, coronary artery bypass graft, percutaneous coronary intervention, or experienced acute coronary syndrome were identified from medical records and interviewed a year later. Descriptive statistics were used to calculate the occurrence of risk variables, medication use, and index events associated with low-density lipoprotein cholesterol (LDL-C), hemoglobin A1c, and blood pressure (BP). RESULTS A total of 402 participants (13.9% female) were interviewed, and their medical records were reviewed. Among the study population, 74.4% had a smoking history, 35.4% had dyslipidemia, 33.1% did not meet the BP target, and only 28.4% achieved the LDL-C target. Additionally, less than half (43.8%) participated in physical activity for >150 min/week. Only 15.6% of the patients among the centers who had scored >8 for the guideline-based target score. CONCLUSIONS Most patients did not meet the guidelines for secondary prevention, primarily due to the high prevalence of dyslipidemia and physical inactivity, although some achieved the LDL-C target.
Congenital heart disease screening program in elementary schools: a research-based policy Dinarti, Lucia Kris; Hartopo, Anggoro Budi; Hadwiono, Muhammad Reyhan; Wiradhika, Abdul Majid Halim; Meliala, Andreasta; Putri, Likke Prawidya; Fajarwati, Prahesti; Anggrahini, Dyah Wulan
BKM Public Health and Community Medicine Vol 39 No 01 (2023)
Publisher : Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/bkm.v39i01.5783

Abstract

Purpose: CHD is a condition where heart abnormalities develop before birth and can lead to severe complications such as heart failure and premature death, especially among younger adults. Delayed diagnosis and treatment worsen the situation for CHD patients. Early screening can prevent CHD and ensure timely interventions. This study discusses the latest advancements in CHD screening for primary school children and the valuable insights gained from the program. Method: The CHD screening program in Yogyakarta province involved three stages: consolidation, implementation, and incorporation. During the consolidation stage, key decision-makers in the province and local health offices were involved. Primary healthcare workers and primary school teachers were trained to deliver the screening during the implementation stage. Stakeholders, health workers, and teachers were invited to discuss the results, and the Provincial Governor's office was engaged during the incorporation stage. Results: In 2018–2019, 18 CHDs were identified from 6,116 school-age children in 4 districts in Indonesia. The screening program was led by academics in the Universitas Gadjah Mada through 3 stages: consolidation, implementation, and incorporation. Strong collaboration with local stakeholders has contributed to the program's success in engaging 130 schools, 60 community health centers, and 190 health workers. Several opportunities for improvement are: strengthening the capacity and number of health providers at health centers to screen CHDs using 12-lead electrocardiography, addressing patients' reluctance to visit the health facility due to the COVID-19 pandemic, and motivating parents to have their children checked. Conclusion: CHD screening using 12-lead electrocardiography and auscultation should be part of primary school health screenings. Academics can train health workers, and local governments can provide funding and prepare health facilities for follow-up treatment.
Co-Authors Abdul Majid Halim Wiradhika Abdul Majid Halim Wiradhika Abdul S Wahab, Abdul S Abdus Samik Wahab Ade Meidian Ambari Ahmad Hamim Sadewa Alifia Salsabila Ambari, Ade Meidian Anandini, Hesti Andreasta Meliala Anggraeni, Vita Yanti Anggrahini, Dyah Wulan Annis Rakhmawati Anwar Santoso Anwar Santoso Arityanti, Dean Armalya Pritazahra Armalya Pritazahra Azhafid Nashar Badai Bhatara Tiksnadi Baiq Gerisa Rahmi Faharani Baiq Gerisa Rahmi Faharani Bambang Budi Siswanto Bambang Dwiputra Bambang Irawan Bambang Irawan Basuni Radi Budi Yuli Setianto Cholid Tri Tjahjono Citra Dewi Wahyu Fitria Desandri, Dwita Rian Detty Siti Nurdiati Deva Bachtiar Deva Bachtiar Dwiputra, Bambang Dyah Samti Mayasari Dyah Wulan Anggrahini Eko Budiono Erna Ashlihah Rochmat Erwan, Nabila Erina Evita Devi Noor Rahmawati Fajarwati, Prahesti Febrianora, Mega Fika Humaeda Assilmi Firandi Saputra Fitra, Maha Gharini, Putrika Prastuti Ratna Gumilang, Rizki Amalia Hariadi Hariawan Hariadi Hariawan Hasan, Harris Hasanah Mumpuni Hendry Purnasidha Bagaswoto Hergaf, Indah Widyasari I Dewa Putu Pramantara Ika Trisnawati Indah Sukmasari Indra Widya Nugraha Ira Puspitawati Iri Kuswadi Irsad Andi Arso Irsad Andi Arso Irsad Andi Arso Irsad Andi Arso, Irsad Andi Iswandi Darwis Jarir At Thobari Jarir At Thobari Jati, Lintang Daru Julia Sari Kathrine, Anita Septiana Maria Kelvin Supriami Krevani, Citra Kiki Krisdinarti, Lucia Likke Prawidya Putri Lucia Kris Dinarti Lucia Kris Dinarti Lucia Kris Dinarti Lucia Kris Dinarti Lucia Kris Dinarti Lucia Kris Dinarti Lucia Krisdinarti Lucida Kris Dinarti, Lucida Kris Luhur Pribadi Luhur Pribadi Lukman Ade Chandra Lukman Ade Chandra M. Taufik Ismail M. Yogi Riyantama Isjoni Makes, Indira Kalyana Mardiah Suci Hardianti Megawati Abubakar Megawati Abubakar Metalia Puspitasari Muhammad Gahan Sarwiko Muhammad Gahan Satwiko Muhammad Gahan Satwiko Muhammad Reyhan Hadwiono Muhammad Reyhan Hadwiono Muhammad Reyhan Hadwiono Muhammad Reyhan Hadwiono Muhammad Ridwan Nahar Taufiq Nahar Taufiq Nahar Taufiq, Nahar Noriaki Emoto Nu Pravitasari Pamrayogi Hutomo Pompini Agustina Sitompul Pompini Agustina Sitompul Prasetia, Arif Eka Prasetya, Arif Eka Putri Ayudhia Trisnasari Putrika Prastuti Ra Gharini Putrika Prastuti Ra Gharini Qhabibi, Faqrizal Ria Raden Heru Prasanto Rahadiyani, IDA Swasty Rahayu, Dian Herlusiatri Raynaldo, Abdul Halim Real Kusumanjaya Marsam Rita Hamdani Rizki Amalia Gumilang Rochmat, Muflihatul Baroroh Royhan Rozqie setiaji, dimas Shiddiq, Achmad Sjughiarto, M.Afies Susanti, Vina Yanti Susilowati, Eliana Syaoqi, Muhammad Tarsidin, Najmi Fauzan Togi Junice Hutadjulu Togi Junice Hutadjulu Tri Asti Isnariani Tri Asti Isnariani Umi Sa'adatun Nikmah Umi Sa'adatun Nikmah Vera Dewanto Vera Dewanto Vienna Rosalinda Vina Yanti Susanti Vita Yanti Anggraeni Vita Yanti Anggraeni Winardi Emmanuel Setiawan Wiradhika, Abdul Majid Halim Yasmine Fitrina Siregar Yulia Wardhani